Ludlow J - Search Results

1

Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma.

Wei X, Choudhury Y, Lim WK, Anema J, Kahnoski RJ, Lane B, Ludlow J, Takahashi M, Kanayama HO, Belldegrun A, Kim HL, Rogers C, Nicol D, Teh BT, Tan MH. Wei X, et al. Among authors: ludlow j. Sci Rep. 2017 Aug 4;7(1):7342. doi: 10.1038/s41598-017-07191-y. Sci Rep. 2017. PMID: 28779136 Free PMC article.

2

Inactivation of BHD in sporadic renal tumors.

Khoo SK, Kahnoski K, Sugimura J, Petillo D, Chen J, Shockley K, Ludlow J, Knapp R, Giraud S, Richard S, Nordenskjöld M, Teh BT. Khoo SK, et al. Among authors: ludlow j. Cancer Res. 2003 Aug 1;63(15):4583-7. Cancer Res. 2003. PMID: 12907635

3

Mitogenic activity of steroidogenesis-inducing protein (SIP) during hypoxic stress of human ovarian carcinoma cells.

Krucher NA, Krtolica A, Lincoln J, Khan SA, Rodriguez-Rodriguez L, Ludlow JW. Krucher NA, et al. Among authors: ludlow jw. Cancer Lett. 1998 Nov 27;133(2):205-14. doi: 10.1016/s0304-3835(98)00234-1. Cancer Lett. 1998. PMID: 10072171 Free article.

4

Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr.

Shostak LD, Ludlow J, Fisk J, Pursell S, Rimel BJ, Nguyen D, Rosenblatt JD, Planelles V. Shostak LD, et al. Among authors: ludlow j. Exp Cell Res. 1999 Aug 25;251(1):156-65. doi: 10.1006/excr.1999.4568. Exp Cell Res. 1999. PMID: 10438581 Free article.

5

Hypoxia arrests ovarian carcinoma cell cycle progression, but invasion is unaffected.

Krtolica A, Ludlow JW. Krtolica A, et al. Among authors: ludlow jw. Cancer Res. 1996 Mar 1;56(5):1168-73. Cancer Res. 1996. PMID: 8640779

6

CD44 splice variant expression in clear cell carcinoma of the ovary.

Rodríguez-Rodríguez L, Sancho-Torres I, Leakey P, Gibbon DG, Comerci JT, Ludlow JW, Mesonero C. Rodríguez-Rodríguez L, et al. Among authors: ludlow jw. Gynecol Oncol. 1998 Nov;71(2):223-9. doi: 10.1006/gyno.1998.5108. Gynecol Oncol. 1998. PMID: 9826464 Free article.

7

Interaction between the retinoblastoma protein and protein phosphatase 1 during the cell cycle.

Berndt N, Ludlow JW. Berndt N, et al. Methods Mol Biol. 2004;281:17-32. doi: 10.1385/1-59259-811-0:017. Methods Mol Biol. 2004. PMID: 15220519

8

Use of immunocomplexed substrate for detecting PP1 activity.

Ludlow JW, Nelson DA, Krucher NA. Ludlow JW, et al. Methods Mol Biol. 1998;93:137-43. doi: 10.1385/0-89603-468-2:137. Methods Mol Biol. 1998. PMID: 9664532 No abstract available.

9

Interaction of the retinoblastoma protein (pRb) with the catalytic subunit of DNA polymerase delta (p125).

Krucher NA, Zygmunt A, Mazloum N, Tamrakar S, Ludlow JW, Lee MY. Krucher NA, et al. Among authors: ludlow jw. Oncogene. 2000 Nov 16;19(48):5464-70. doi: 10.1038/sj.onc.1203930. Oncogene. 2000. PMID: 11114723

10

Hypoxia-induced pRB hypophosphorylation results from downregulation of CDK and upregulation of PP1 activities.

Krtolica A, Krucher NA, Ludlow JW. Krtolica A, et al. Among authors: ludlow jw. Oncogene. 1998 Nov 5;17(18):2295-304. doi: 10.1038/sj.onc.1202159. Oncogene. 1998. PMID: 9811460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters